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Efficient Macrocyclization of Small Peptides
Significance: Cyclic peptides have recently emerged as a new source of drug molecules, but very few in clinical use are derived from natural sources. The main problem is associated with their synthesis, which often suffers from C-terminal epimerization, cyclooligomerization, and byproduct formation during macrocyclization. Shipman and coworkers have developed a simple, mild, and efficient macrocyclization strategy, which involves the incorporation of an oxetane ring, for synthesizing cyclic peptides in good yields by using an appropriate coupling reagent.
Comment: Cyclic peptide drugs are more useful than the linear peptides, but their synthesis is quite challenging. The present approach shows that macrocyclization of head-to-tail peptide can be improved by substituting one of the backbone amide C=O bonds with a simple oxetane ring. In addition, a variety of cyclic peptides with challenging ring sizes (tetra-, penta-, or hexapeptides) were synthesized. Further study showed that the bioactivity does not change upon replacing the amide C=O bond with an oxetane ring. This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
